¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immediate hemiplegia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • immediate traumatic paraplegia
    ¿Ü»óÁ÷ÈÄÇϹݽŸ¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double hemiplegia
    Áߺ¹¹Ý¸¶ºñ
  • facial hemiplegia
    ¾ó±¼¹Ý¸¶ºñ
  • flaccid hemiplegia
    À̿Ϲݸ¶ºñ
  • hemiplegia
    ¹Ý¸¶ºñ
  • homolateral hemiplegia
    °°ÀºÂʹݸ¶ºñ
  • hysteric hemiplegia
    È÷½ºÅ׸®¹Ý¸¶ºñ
  • infantile hemiplegia
    ¿µ¾Æ¹Ý¸¶ºñ
  • spastic hemiplegia
    °æÁ÷¹Ý¸¶ºñ
  • spinal hemiplegia
    ô¼ö¹Ý¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immediate hypersensitivity
    Áï½Ã(Çü)°ú¹ÎÁõ(ñíãÁúþΦÚÂñø).
  • immediate hypersensitivity
    Áï½ÃÇü°ú¹Î¹ÝÀÀ
  • immediate ligature
    Áï½Ã°áÂû(Áï½Ã°áÂû).
  • alternate hemiplegia
    ±³´ë¼º Æí¸¶ºñ(ÎßÓÛàõø¶ Ýö).
  • alternating hemiplegia =h. alterans
    ±³´ë¼º Æí¸¶ºñ(ÎßÓÛàõø¶Ø«Ýö).
  • hemiparalysis =hemiplegia
    Æí¸¶ºñ (ø¶ Ýö).
  • hemiplegia
    ÆíÃø¸¶ºñ
  • hemiplegia
    Æí¸¶ºñ, ¹Ý½ÅºÒ¼ö.
  • hemiplegia alternans
    ±³´ë¼º Æí¸¶ºñ.
  • hemiplegia alternans abducens ³ª
    ¿ÜÀü½Å°æ±³´ë¼º Æí¸¶ºñ.
  • hemiplegia alternans facialis <³ª>
    ¾È¸é½Å°æ±³´ë(¼º) Æí¸¶ºñ
  • hemiplegia alternans facialis ³ª
    ¾È¸é(äÔØü)½Å°æ±³´ë¼º Æí¸¶ºñ.
  • hemiplegia alternans hypogloisca <³ª>
    ¼³ÇϽŰ汳´ë(¼º) Æí¸¶ºñ
  • hemiplegia alternans hypogloisca ³ª
    ¼³ÇϽŰ汳´ë¼º Æí¸¶ºñ.
  • hemiplegia alternans infima ³ª
    ÃÖÇÏ(õÌù»)±³´ë¼º Æí¸¶ºñ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immediate hypersensitivity
    Áï½ÃÇü°ú¹Î¹ÝÀÀ
  • immediate hypersensitivity
    Áï½Ã(Çü)°ú¹ÎÁõ(ñíãÁúþΦÚÂñø).
  • immediate ligature
    Áï½Ã°áÂû(Áï½Ã°áÂû).
  • immediate memory
    Á÷Á¢±â¾ï(òÁïÈÑÀåâ).
  • immediate memory
    Á÷Á¢±â¾ï(òÁïÈÑÀåâ)
  • immediate pigment darkening
    Áï½ÃÇü »ö¼ÒÄ§Âø
  • immediate root filling
    Áï½Ã±Ù°üÃæÀü(ñíãÁÐÆÎ·õöîó).
  • immediate separation
    Áï½ÃÀ̰³¹ý (¡­ìÆËÒÛö).
  • immediate transfusion
    Á÷Á¢¼öÇ÷(òÁïÈâÃúì), Áï°¢¼öÇ÷, Áï½Ã¼öÇ÷.
  • immediate traumatic paraplegia
    Áï½Ã¿Ü»ó¼º ´ë¸¶ºñ.
  • immediate traumatic paraplegia
    Áï½Ã¿Ü»ó¼º ´ë¸¶ºñ.
  • immediate union
    Á¦ÀÏÀ¯ÇÕ.
  • alternate hemiplegia
    ±³´ë¼º Æí¸¶ºñ(ÎßÓÛàõø¶ Ýö).
  • alternating hemiplegia =h. alterans
    ±³´ë¼º Æí¸¶ºñ(ÎßÓÛàõø¶Ø«Ýö).
  • ascending hemiplegia
    »óÇ༺ Æí¸¶ºñ(¡­ø¶ Ýö).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
WM Waldenstrom macroglobulinemia; ward manager; warm and moist; Wernicke-Mann [hemiplegia]; wet mount; ...
IAR immediate asthma reaction; inhibitory anal reflex; iodine-azide reaction
IDLH immediate danger to life and health
IEA immediate early antigen; immunoelectroadsorption; immunoelectrophoretic analysis; infectious equine ...
IEG immediate early gene
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IBR Immediate breast reconstruction
IE Immediate early
MIE Major Immediate Early
IAR immediate asthmatic reaction
IE-1 immediate early 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immediate response
    Ãʱ⠹ÝÀÀ
    ¾Ë·¹¸£±â ¹ÝÀÀ°ú °°ÀÌ À¯¹ßÀÎÀÚ¿¡ Á¢ÇÑ ÈÄ, ¸î ÃÊ-¸î ºÐ À̳»¿¡ ÃâÇöÇÏ´Â ¹ÝÀÀ.
  • immediate separation
    Áï½Ã À̰³¹ý
  • immediate transfusion
    Á÷Á¢ ¼öÇ÷, Áï°¢ ¼öÇ÷, Áï½Ã ¼öÇ÷
    Áß°£ ¿ë±â³ª Ç×ÀÀ°íÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°í, ¾î¶² »ç¶÷À¸·ÎºÎÅÍ ´Ù¸¥ »ç¶÷¿¡°Ô·Î Ç÷¾×À» Á÷Á¢ ¿Å±â´Â °Í.
  • immediate-type
    Áï½ÃÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
immediate early gene Class of genes whose expression is low or undetectable in quiescent cells, but whose transcription is activated within minutes after extracellular stimulation such as addition of a growth factor. C fos and c myc proto-oncogenes were among the first IEG's to be identified. Many IEG's encode transcription factors and therefore have a regulatory function.
(18 Nov 1997)
immediate-early proteins Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesised just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesised immediately after the resting cell is stimulated by extracellular signals.
(12 Dec 1998)
immediate flap A flap raised completely and transferred at the same stage.
Synonym: immediate flap.
(05 Mar 2000)
immediate hypersensitivity An exaggerated immune response mediated by antibodies, in particular IgE.
See: allergy.
(05 Mar 2000)
immediate hypersensitivity reaction An immune response mediated by antibody, usually IgE, which occurs within minutes after a second encounter with an antigen, resulting in the release of histamine and subsequent swelling and vasodilation.
(05 Mar 2000)
immediate insertion denture A complete or partial denture constructed for insertion immediately following the removal of natural teeth.
Synonym: immediate insertion denture.
(05 Mar 2000)
immediate percussion The striking of the part under examination directly with the finger or a plessor, without the intervention of another finger or plessimeter.
Synonym: direct percussion.
(05 Mar 2000)
immediate posttraumatic automatism A posttraumatic state in which the patient performs automatically without immediate or later memory of that behaviour.
(05 Mar 2000)
immediate posttraumatic convulsion A convulsion beginning very soon after injury.
(05 Mar 2000)
immediate reaction Local or generalised response that begins within a few minutes to about an hour after exposure to an antigen to which the individual has been sensitised.
See: skin test, wheal-and-erythema reaction.
Synonym: early reaction.
(05 Mar 2000)
immediate transfusion Transfusion of blood from the donor to the receptor, either through a tube connecting their blood or by suturing the vessels together.
Synonym: immediate transfusion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á